Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/JBIO/vs peers

JBIOJade Biosciences, Inc.vs its industry peers

A metric-by-metric comparison of Jade Biosciences, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
JBIOJade Biosciences, Inc.Esta$866M#6—2.0x#4——-83.0%#11—-29.0%#7——39.1%#3—
SVRASavara Inc$971M#1—6.8x#123777.4x#7—-23.9%#8-48072.8%#7-82.7%#12-93.6%#6—13.6%#5—
MLTXMoonLake Immunotherapeutics$969M#2—2.3x#6——-91.1%#12—-53.1%#11-491.6%#7—13.0%#6—
ORICOric Pharmaceuticals, Inc.$958M#3—2.5x#8——-1.3%#4—-34.0%#8-40.4%#4—-29.8%#7—
RIGLRIGEL PHARMACEUTICALS INC$944M#43.0x#12.2x#53.2x#364.1%#21999.1%#142.6%#186.3%#130.6%#2—60.0%#1—
OBXGazelle Parent, Inc.$890M#5————-21.1%#7——————
VSTM$865M#7—17.3x#1328.0x#6209.1%#1-60.3%#10-550.3%#6-419.1%#13————
ANROAlto Neuroscience, Inc.$864M#8—3.9x#10——-2.9%#5—-28.8%#6——55.0%#2—
CYRX$846M#9—1.7x#34.8x#412.4%#5168.2%#2-20.9%#416.0%#3-16.5%#34#1——
CRVS$816M#10—3.6x#9——75.4%#3—-6.8%#5——20.6%#4—
COLL$768M#1118.6x#22.5x#71.0x#123.6%#3-8.7%#623.0%#220.2%#262.0%#14#1——
AKTS$755M#12—1.6x#1————0.0%#4————
ARDX$746M#13—5.0x#111.8x#222.1%#4-59.0%#9-10.1%#3-41.6%#9-52.3%#5———
WVE$691M#14—1.7x#216.2x#5-60.5%#6-110.7%#13-504.1%#5-50.9%#10——-61.2%#8—

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

JBIO's peers

SVRAMLTXORICRIGLOBXVSTMANROCYRXCRVSCOLLAKTSARDXWVE
← JBIO overview